Skip to main content
logo
Vigonvita Life Sciences Co., Ltd. (HKG:2630)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
81.20
-0.70 (-0.85%)
Sep 10, 2026, 4:08 PM HKT

Vigonvita Life Sciences Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Revenue
217.26102.111.83199.65
Revenue Growth
-762.88%-94.07%-
Gross Profit
186.8180.683.49193.64
Operating Income
-265.37-334.28-203.667.25
Net Income
-304.78-355.72-211.412.09
Earnings Per Share
-1.89-2.33-1.450.08
EPS Growth
----

Revenue by Geography
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
People's Republic of China (PRC)
217.1101.9411.79198.98
Uzbekistan
0.160.160.040.67
Total
217.26102.111.83199.65

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Cash & Investments
405.79517.69121.3596.22
Total Debt
858.46646.57427.72321.03
Net Cash (Debt)
-452.68-128.88-306.37-224.81
Net Cash Growth
----
Net Cash Per Share
-2.81-0.84-2.10-1.56

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Operating Cash Flow
--96.67-108.8530.67
Capital Expenditures
--159.97-77.68-86.72
Free Cash Flow
--256.64-186.53-56.05
Free Cash Flow Growth
----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Gross Margin
85.98%79.02%29.47%96.99%
Operating Margin
-122.14%-327.41%-1721.30%3.63%
Pretax Margin
-140.64%-349.58%-1839.44%3.22%
Profit Margin
-140.28%-348.42%-1786.71%6.05%
FCF Margin
--251.38%-1576.46%-28.07%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
PS Ratio
54.26120.74--